Bamco Inc. NY lifted its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 13.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 489,386 shares of the company's stock after acquiring an additional 58,611 shares during the quarter. Bamco Inc. NY owned 1.75% of Establishment Labs worth $21,176,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Hood River Capital Management LLC purchased a new stake in Establishment Labs in the 2nd quarter valued at $43,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Establishment Labs in the third quarter worth $127,000. Nkcfo LLC purchased a new position in Establishment Labs in the 2nd quarter valued at about $227,000. SG Americas Securities LLC purchased a new position in shares of Establishment Labs during the second quarter valued at approximately $303,000. Finally, Black Swift Group LLC acquired a new stake in shares of Establishment Labs during the third quarter worth $312,000. Hedge funds and other institutional investors own 72.91% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on ESTA. Stephens reiterated an "overweight" rating and issued a $68.00 target price on shares of Establishment Labs in a research note on Wednesday, August 7th. BTIG Research lifted their price target on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a research report on Monday, October 14th. JPMorgan Chase & Co. dropped their price target on Establishment Labs from $61.00 to $50.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 7th. Finally, Citigroup lifted their price target on Establishment Labs from $45.00 to $50.00 and gave the company a "neutral" rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $60.60.
Check Out Our Latest Stock Report on Establishment Labs
Establishment Labs Stock Performance
ESTA traded down $1.32 during trading on Tuesday, hitting $44.68. The company's stock had a trading volume of 66,249 shares, compared to its average volume of 387,452. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The firm's 50 day moving average price is $43.31 and its two-hundred day moving average price is $44.63. Establishment Labs Holdings Inc. has a 12 month low of $22.05 and a 12 month high of $60.12.
About Establishment Labs
(
Free Report)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
See Also
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
